Table 2.
Antiproliferative activity of the neocryptolepine derivatives 3a–3d, 4a, and 4b against the human leukemia MV4-11 cell line.
Compound | n | R1 | R2 | R3 | Yield, % | IC50 (μM) |
---|---|---|---|---|---|---|
3a | 1 | H | Me | Me | 91 a | 0.549 ± 0.108 |
3b | 1 | Me | Me | Me | 83 a | 0.427± 0.092 |
3c | 1 | Cl | Me | Me | 84 a | 0.790 ± 0.302 |
3d | 0 | H | Me | Me | 89 a | 0.464 ± 0.141 |
4a | 1 | H | Me | Me | 90 b | 0.680 ± 0.215 |
4b | 0 | Cl | Me | Me | 84 b | 2.330 ± 1.015 |
a Yield of ureidation of the precursor amine 2; b Yield of thioureidation of the precursor amine 2. The IC50 value is defined as the concentration of a compound that corresponds to a 50% growth inhibition. Data are expressed as the mean ± SD.